UBS Group’s AlerisLife Inc ALR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,623
| Closed | -$3.09K | – | 11286 |
|
|
2022
Q4 | $3.09K | Sell |
5,623
-1,879
| -25% | -$1.56K | ﹤0.01% | 9569 |
|
|
2022
Q3 | $7K | Sell |
7,502
-469
| -6% | -$539 | ﹤0.01% | 8958 |
|
|
2022
Q2 | $9K | Buy |
7,971
+4,815
| +153% | +$7.82K | ﹤0.01% | 8235 |
|
|
2022
Q1 | $7K | Buy |
3,156
+1,258
| +66% | +$3.37K | ﹤0.01% | 8903 |
|
|
2021
Q4 | $5K | Sell |
1,898
-24
| -1% | -$87 | ﹤0.01% | 9458 |
|
|
2021
Q3 | $8K | Sell |
1,922
-681
| -26% | -$3.25K | ﹤0.01% | 8258 |
|
|
2021
Q2 | $15K | Sell |
2,603
-43,851
| -94% | -$250K | ﹤0.01% | 7667 |
|
|
2021
Q1 | $284K | Buy |
46,454
+40,221
| +645% | +$290K | ﹤0.01% | 5245 |
|
|
2020
Q4 | $43K | Sell |
6,233
-1,957
| -24% | -$11.3K | ﹤0.01% | 6327 |
|
|
2020
Q3 | $42K | Sell |
8,190
-2,971
| -27% | -$14.2K | ﹤0.01% | 5783 |
|
|
2020
Q2 | $43K | Buy |
11,161
+6,584
| +144% | +$23.5K | ﹤0.01% | 6001 |
|
|
2020
Q1 | $13K | Buy |
4,577
+2,684
| +142% | +$11.3K | ﹤0.01% | 6792 |
|
|
2019
Q4 | $7K | Buy |
1,893
+1,637
| +639% | +$7.87K | ﹤0.01% | 7478 |
|
|
2019
Q3 | $1K | Buy |
256
+132
| +106% | +$677 | ﹤0.01% | 7877 |
|
|
2019
Q2 | $0 | Sell |
124
-295
| -70% | -$1.69K | ﹤0.01% | 8274 |
|
|
2019
Q1 | $4K | Buy |
419
+396
| +1,722% | +$3.38K | ﹤0.01% | 7288 |
|
|
2018
Q4 | $0 | Hold |
23
| – | – | ﹤0.01% | 8417 |
|
|
2018
Q3 | $0 | Sell |
23
-379
| -94% | -$4.31K | ﹤0.01% | 8377 |
|
|
2018
Q2 | $6K | Buy |
402
+116
| +41% | +$1.51K | ﹤0.01% | 7431 |
|
|
2018
Q1 | $3K | Buy |
286
+263
| +1,143% | +$3.82K | ﹤0.01% | 7462 |
|
|
2017
Q4 | $0 | Hold |
23
| – | – | ﹤0.01% | 8193 |
|
|
2017
Q3 | $0 | Sell |
23
-422
| -95% | -$6.78K | ﹤0.01% | 8100 |
|
|
2017
Q2 | $6K | Buy |
445
+234
| +111% | +$4.23K | ﹤0.01% | 7069 |
|
|
2017
Q1 | $4K | Sell |
211
-40
| -16% | -$980 | ﹤0.01% | 7107 |
|
|
2016
Q4 | $6K | Buy |
251
+241
| +2,410% | +$6.4K | ﹤0.01% | 7178 |
|
|
2016
Q3 | $0 | Buy |
10
+2
| +25% | +$43 | ﹤0.01% | 8025 |
|
|
2016
Q2 | $0 | Sell |
8
-110
| -93% | -$2.37K | ﹤0.01% | 8054 |
|
|
2016
Q1 | $3K | Sell |
118
-704
| -86% | -$17.3K | ﹤0.01% | 7224 |
|
|
2015
Q4 | $26K | Buy |
822
+705
| +603% | +$23.7K | ﹤0.01% | 6479 |
|
|
2015
Q3 | $4K | Sell |
117
-201
| -63% | -$7.63K | ﹤0.01% | 7863 |
|
|
2015
Q2 | $15K | Hold |
318
| – | – | ﹤0.01% | 7143 |
|
|
2015
Q1 | $14K | Sell |
318
-289
| -48% | -$10.9K | ﹤0.01% | 7374 |
|
|
2014
Q4 | $25K | Buy |
+607
| New | +$25.4K | ﹤0.01% | 7335 |
|
UBS Group's ALR Position: Q1 2023 in Review
UBS Group sold out of AlerisLife Inc (ALR) in Q1 2023, closing a stake of 5,623 shares — an estimated $3.09K sold.
UBS Group first reported a position in ALR in Q4 2014 and held it in 33 quarters. The position peaked at $284K in Q1 2021. 1 fund tracked by Wall St. Rank holds ALR as of Q1 2023.
- UBS Group reported no remaining AlerisLife Inc position as of Q1 2023 after selling out during the quarter.
- UBS Group sold 5,623 AlerisLife Inc shares in Q1 2023, an estimated $3.09K.
- UBS Group first reported a position in AlerisLife Inc in Q4 2014 and held it in 33 quarters.
- UBS Group's AlerisLife Inc position peaked at $284K in Q1 2021.
- 1 fund tracked by Wall St. Rank held AlerisLife Inc as of Q1 2023.
Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.